🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Conclusions of a wonderful Indian Myeloma Congress2025 at TMC Kolkata. It was great to meet many teachers, mentors, friends & students. Great scientific program & arrangements by Prof Reena Nair and her team. Pankaj Malhotra Dr Velu Nair Prantar Chakrabarti 3.0 Nikita Mehra IMAGe

Grateful for the opportunity to share my work, connect with experts, and learn from inspiring discussions. Thank you IMAGe #IMC2025 Pankaj Malhotra

In observance of Multiple Myeloma Awareness Month, the Department of Medical Social Services, in partnership with the Adult Hemato-Lymphoid unit of Department of Medical Oncology, hosted a Patient Support Group Meeting. The session aimed to raise awareness about multiple myeloma,

I have zero respect for a researcher, perched in an ivory tower publishing thousands of papers, who publicly tells a practicing clinician, who spends their day caring for patients, that they are a "nobody" because they have not published a paper.

Delighted to share that ive joined the dept of clinical hematology & medical oncology at PGIMER, Chandigarh as Assistant Professor. A dream come true. Indebted to Pankaj Malhotra for the mentorship and support Excited to continue to serve the people and hopefully do meaningful research

A LMIC perspective on managing adverse events in haematological malignancy. Privileged to lead this The Lancet paper with authors from Argentina, Brazil, Zambia and Kenya. A wonderful experience. Tata Memorial Hospital thelancet.com/journals/lanha…

A heartfelt goodbye to Tata Memorial Centre, Punjab Homi Bhabha Cancer Hospital & Research Centre, where I had the privilege to serve as faculty for almost 2 years. I am grateful for the learning, friendships, and unwavering support. Dr. Ashish Gulia Seema Gulia Pooja Prasad

Glad to share that I've joined my alma mater, PGIMER Chandigarh, as faculty in the Dept of Clinical Hematology and MedOnc PGI Clinical Hematology and Medical Oncology Always grateful to Pankaj Malhotra for his continued support and leadership Looking forward to contributing to patient care, academics, and research

Aditya Jandial, MD, DM PGI Clinical Hematology and Medical Oncology Pankaj Malhotra Gaurav Prakash M.D. A Khadwal Charanpreet Singh Congratulations 🎉👏🏽 Very well deserved 💪🏽

Aditya Jandial, MD, DM PGI Clinical Hematology and Medical Oncology Pankaj Malhotra Gaurav Prakash M.D. Congratulations Dr Aditya Welcome back to PGI

Aditya Jandial, MD, DM PGI Clinical Hematology and Medical Oncology Pankaj Malhotra Gaurav Prakash M.D. A Khadwal Congratulations, Dr. Aditya! Best wishes. Been looking forward to this update 🙂

Our Dept of Cl Hematology & Medical Oncology at #PGI organised an event with school and college students against tobacco. 🚭🚭 ▶️Our fight against cancer is relentless and it shall continue on all fronts ▶️Prevention is the most important aspect #NoTobaccoDay #HealthyChoices

Arjun D. Law has been so much more than a mentor, more like a (tor)mentor! From medicine to life itself, he has taught me everything with humour and ruthless honesty. Grateful. Traumatised. Wouldn’t change a thing. ❤️

Comparable efficacy of venetoclax 50mg with posaconazole versus venetoclax 400mg in newly diagnosed AML patients: pharmacokinetics and clinical outcomes. ascopubs.org/doi/10.1200/JC… #ASCO2025 #POSTER #Thesis-Great full to mentors Gaurav Prakash M.D. Pankaj Malhotra DrArihant@jain

It was truly a great learning experience — a masterclass in every sense! Nitin Jain Grateful to have been part of it!

Glad to share a CML-focused podcast for South Asian patients, recorded for Ravi vij — a platform dedicated to raising cancer awareness among patients and healthcare professionals. Thank you, ravi vij for the opportunity. youtu.be/nAU8VO26jAw?si…

📢 Now out in British Journal of Haematology 🎊🎉 Our latest work from the Princess Margaret Cancer Centre explores how GvHD prophylaxis influences the risk of second primary malignancies after allogeneic transplants using a large cohort of 1,418 patients (>6000 person-years of follow up) onlinelibrary.wiley.com/doi/10.1111/bj…

Rishu Raj Singh 31 cr = bone marrow transplant of 200 cancer patients.

bct.apbmt.org/articles/bct-2… 🧵5 Key Takeaways from Our Study on Composite MRD in Myeloma ASCT👇 📍Published in Blood Cell Therapy (APBMT) 1.🔍 Pre-ASCT cMRD negativity = better outcomes → 3-yr TTNT: 91% vs. 67% (p=0.027) 2.📊 Pre-ASCT MRD more predictive than post-ASCT → Post-ASCT